Left Atrium Enlargement: Clinical Significance and Management

Definition and Measurement

The American College of Cardiology defines moderate left atrial enlargement as indexed left atrial volume of 42-48 mL/m², which is a nonspecific marker of chronic cardiac stress that warrants systematic evaluation for underlying valvular disease, left ventricular dysfunction, hypertension, and atrial fibrillation risk 1
Measurement should use the biplane disk summation technique at end-ventricular systole, excluding the left atrial appendage and pulmonary veins from endocardial tracing to avoid overestimation 1
Single anteroposterior diameter measurements are inadequate and should not be relied upon for clinical decision-making, according to the American Heart Association 2, 1

Left atrial dilation reflects chronic pressure or volume overload from multiple potential etiologies including valvular disease, left ventricular diastolic dysfunction, systolic heart failure, and hypertension, as stated by the American Heart Association 3, 1
Progressive dilation causes myocyte disarray and fibrotic changes, which compromise atrial contractile function and create substrate for atrial arrhythmias, according to the European Society of Cardiology 3
The atrium normally compensates through three phases: reservoir, conduit, and contractile function, as described by the American College of Cardiology 3
Most patients with moderate left atrial enlargement are asymptomatic, but when symptoms occur they typically reflect the underlying cardiac condition rather than the atrial enlargement itself, as noted by the American College of Cardiology 1
Potential manifestations include dyspnea and exercise intolerance from elevated left atrial pressure and pulmonary venous congestion, as reported by the American Heart Association 4
Palpitations from increased risk of atrial arrhythmias, particularly atrial fibrillation, are a concern, according to the American College of Cardiology 3, 5
Fatigue related to reduced cardiac output, especially if atrial contractile function is impaired, is a possible symptom, as stated by the European Society of Cardiology 3

Evaluate mitral regurgitation severity using vena contracta width, effective regurgitant orifice area, and regurgitant volume, as recommended by the American College of Cardiology 6, 1
Assess for mitral stenosis using valve area, mean gradient, and pressure half-time, as this causes direct left atrial pressure overload, according to the American Heart Association 1
Evaluate aortic regurgitation with vena contracta measurement, as chronic aortic regurgitation causes left ventricular dilation and secondary left atrial enlargement, as stated by the European Society of Cardiology 6, 1
Measure left ventricular ejection fraction and assess for regional wall motion abnormalities, as systolic dysfunction commonly leads to left atrial enlargement, according to the American College of Cardiology 1
Evaluate diastolic function comprehensively using mitral inflow patterns, tissue Doppler imaging, E/e' ratio, and left atrial pressure estimation, as recommended by the American Heart Association 1

Left atrial enlargement is both a consequence and a cause of atrial fibrillation, creating a vicious cycle where atrial fibrillation causes further dilation and fibrosis, perpetuating the arrhythmia, as described by the European Society of Cardiology 3
Functional measures of left atrial phasic function can predict atrial fibrillation even in structurally normal atria, emphasizing that enlargement represents advanced disease, according to the American College of Cardiology 3

If no significant underlying cause is identified and the patient is asymptomatic, repeat echocardiography in 1-2 years to assess for progression, as recommended by the American College of Cardiology 1
Maintain an aggressive strategy for preserving sinus rhythm when atrial fibrillation develops, as atrial fibrillation is associated with progressive heart failure and mortality in patients with left atrial enlargement, according to the American Heart Association 5
Initiate anticoagulation with warfarin after even one or two episodes of paroxysmal atrial fibrillation, as the threshold for thromboembolism risk is low in patients with left atrial enlargement, as stated by the American College of Cardiology 5
Consider valve repair over replacement when feasible for mitral regurgitation, particularly in asymptomatic patients with preserved left ventricular function and high likelihood of successful repair, as recommended by the European Society of Cardiology 7

Do not overlook diastolic dysfunction as the underlying cause, particularly in patients with hypertension or preserved ejection fraction, as this is frequently missed, according to the American College of Cardiology 1
Do not rely on single-dimension measurements, as volumetric assessment is substantially more accurate for risk stratification and serial monitoring, as stated by the American Heart Association 2, 1
Ensure proper echocardiographic technique by excluding pulmonary veins and left atrial appendage from measurements, as inclusion leads to overestimation of left atrial volume, according to the American College of Cardiology 1
Do not delay anticoagulation in patients who develop even brief episodes of atrial fibrillation, as stroke risk is elevated even with paroxysmal atrial fibrillation in the setting of left atrial enlargement, as recommended by the American College of Cardiology 5